RT Journal Article
SR Electronic
T1 Development and Validation of a web-based Postoperative <em>Clostridioides difficile</em> infection risk prediction model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.23.20138420
DO 10.1101/2020.06.23.20138420
A1 Woo, Sang H.
A1 Hess, Bryan
A1 Ackermann, Lily
A1 Cowan, Scott W.
A1 Valentine, Jennifer
YR 2020
UL http://medrxiv.org/content/early/2020/06/24/2020.06.23.20138420.abstract
AB Background Clostridioides difficile infection is associated with significant morbidity, mortality and increased costs. Assessment of the postoperative C. difficile infection risk is necessary to improve the outcome of surgical patients.Objective To develop and validate a risk prediction tool for C. difficile infection after surgery.Methods In this retrospective cohort study, 2,451,169 surgical patients from the American College of Surgeons National Surgical Quality Improvement Program Database (ACS-NSQIP) over 2015-2017 were included. Nine predictors were selected for the model: age, preoperative leukocytosis (&gt;12 ×109/L), hematocrit (≤30%), chronic dialysis, insulin dependent diabetes, weight loss, steroid use, presence of preoperative sepsis, and surgery type. A second model included hospital length of stay as a predictor. A predictive model was developed using ACS-NSQIP 2015-2016 training cohort (n=1,435,157) and tested using 2017 validation cohort (n=1,016,012). Multivariate logistic regression was used for the model.Main outcome The primary outcome was postoperative 30-day C. difficile infection (CDI).Results 0.39% of the patients (n=9,675) developed CDI and 42.3% (n=4,091) of CDI occurred post-discharge. The Clostridioides difficile risk prediction model had excellent AUC (area under the receiver operating characteristic curve) for postoperative C. difficile infection (training cohort=0.804, test cohort= 0.803). The model that includes hospital length of stay has a high AUC (training cohort=0.841, test cohort=0.838).Conclusion The C. difficile prediction model provides a robust predictive tool for postoperative C. difficile infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was obtained for this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Thomas Jefferson University institutional review board approved this study and waived informed consent from study participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available at American College of Surgeon (ACS-NSQIP)